ReviewCancer cell international2023

Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages.

Hui Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.